ScholarIQanswers from OpenAlex

Recombinant PTH Infusion in a Child With Sanjad-Sakati Syndrome Refractory to Conventional Therapy

PaperCitations, authors & open-access status

Recombinant PTH Infusion in a Child With Sanjad-Sakati Syndrome Refractory to Conventional Therapy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Recombinant PTH Infusion in a Child With Sanjad-Sakati Syndrome Refractory to Conventional Therapy have?

ScholarIQcitation count

Recombinant PTH Infusion in a Child With Sanjad-Sakati Syndrome Refractory to Conventional Therapy has 4 citations in the OpenAlex counts ScholarIQ stores.

When was Recombinant PTH Infusion in a Child With Sanjad-Sakati Syndrome Refractory to Conventional Therapy published?

ScholarIQyear

Recombinant PTH Infusion in a Child With Sanjad-Sakati Syndrome Refractory to Conventional Therapy has 2024 year in the ScholarIQ index.

What is the open-access status of Recombinant PTH Infusion in a Child With Sanjad-Sakati Syndrome Refractory to Conventional Therapy?

ScholarIQoa status

Recombinant PTH Infusion in a Child With Sanjad-Sakati Syndrome Refractory to Conventional Therapy has diamond oa status in the ScholarIQ index.

What is the DOI of Recombinant PTH Infusion in a Child With Sanjad-Sakati Syndrome Refractory to Conventional Therapy?

ScholarIQdoi

The DOI for Recombinant PTH Infusion in a Child With Sanjad-Sakati Syndrome Refractory to Conventional Therapy is on the source record.

What is the PMID of Recombinant PTH Infusion in a Child With Sanjad-Sakati Syndrome Refractory to Conventional Therapy?

ScholarIQpmid

The PMID for Recombinant PTH Infusion in a Child With Sanjad-Sakati Syndrome Refractory to Conventional Therapy is on the source record.

What is the OpenAlex record for Recombinant PTH Infusion in a Child With Sanjad-Sakati Syndrome Refractory to Conventional Therapy?

ScholarIQopenalex

The OpenAlex for Recombinant PTH Infusion in a Child With Sanjad-Sakati Syndrome Refractory to Conventional Therapy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial